WY 50324 (adatanserin)

structure given in first source; RN given refers to parent cpd

Also Known As:

adatanserin; N-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)tricyclo(3.3.1.1)decane-1-carboxamide; WY 50324 dihydrochloride; WY-50324

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ischemia 03/01/2002 - "Using sodium azide (NaN3)-induced anoxia plus aglycaemia as a model of chemically-induced ischemia in the hippocampal slice, we have evaluated the effects of the novel 5-HT(1A) partial agonist/5-HT(2) receptor antagonist adatanserin and the 5-HT(1A) receptor agonist BAYx3702 on the efflux of endogenous glutamate, aspartate and GABA. "
2.	Hypoxia (Hypoxemia) 03/01/2002 - "Using sodium azide (NaN3)-induced anoxia plus aglycaemia as a model of chemically-induced ischemia in the hippocampal slice, we have evaluated the effects of the novel 5-HT(1A) partial agonist/5-HT(2) receptor antagonist adatanserin and the 5-HT(1A) receptor agonist BAYx3702 on the efflux of endogenous glutamate, aspartate and GABA. "

1.	5-HT1A Serotonin Receptor
2.	Sodium Azide
3.	Glutamic Acid (Glutamate)
4.	gamma-Aminobutyric Acid (GABA)
5.	Aspartic Acid (Aspartate)